PD1-PDL1 inhibitor 1
CAS No. 1675201-83-8
PD1-PDL1 inhibitor 1( PD-1/PD-L1 inhibitor 1 )
Catalog No. M12558 CAS No. 1675201-83-8
PD1-PDL1 inhibitor 1 (CAS 1675201-83-8) is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 6-100 nM in a homogenous time-resolved fluorescence binding assay.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 76 | In Stock |
|
| 5MG | 73 | In Stock |
|
| 10MG | 109 | In Stock |
|
| 25MG | 208 | In Stock |
|
| 50MG | 305 | In Stock |
|
| 100MG | 461 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePD1-PDL1 inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPD1-PDL1 inhibitor 1 (CAS 1675201-83-8) is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 6-100 nM in a homogenous time-resolved fluorescence binding assay.
-
DescriptionPD1-PDL1 inhibitor 1 (CAS 1675201-83-8) is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 6-100 nM in a homogenous time-resolved fluorescence binding assay.
-
In VitroCell Cytotoxicity Assay Cell Line:NK cells and HepG2 cells Concentration:1 μM Incubation Time:3 days Result:Disturbed the interaction between PD-1 and PD-L1.
-
In VivoAnimal Model:BALB/c mice with EMT6 cells Dosage:500 μg/mL; 100 μL Administration:I.p.Result:Increased the survival rates of the mVEGF165b group and mVEGF165b + MUC1 group.mVEGF165b combined with MUC1 results significant retardation of the tumor growth.
-
SynonymsPD-1/PD-L1 inhibitor 1
-
PathwayImmunology/Inflammation
-
TargetPD-1/PD-L1
-
RecptorPD-1/PD-L1
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number1675201-83-8
-
Formula Weight475.576
-
Molecular FormulaC29H33NO5
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 29 mg/mL
-
SMILESO=C([C@H]1N(CC2=C(OC)C=C(OCC3=CC=CC(C4=CC=CC=C4)=C3C)C=C2OC)CCCC1)O
-
Chemical Name2-Piperidinecarboxylic acid, 1-[[2,6-dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-, (2S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chupak, L.S., and Zheng, X. Compounds useful as immunomodulators. PCT/US2014/053695, (2015).
molnova catalog
related products
-
Nofazinlimab
Nofazinlimab (CS1003) is a human anti-PD-1 IgG4 monoclonal antibody used to study unresectable hepatocellular carcinoma (uHCC) and metastatic colorectal cancer.
-
IMMH 010 maleate
IMMH 010 maleate (YPD-30 maleate) is an orally available programmed cell death ligand 1 inhibitor with potential antitumor activity for the study of neurological disorders and advanced malignant solid tumors.
-
Camrelizumab
Camrelizumab (SHR-1210) is a human IgG4-κ monoclonal antibody with high affinity directed against PD-1, binding PD-1 with an affinity of up to 3 nM and inhibiting PD-1/PD-L1 with an IC50 of 0.70 nM.
Cart
sales@molnova.com